[go: up one dir, main page]

NO20011663L - Shelf-stable active ingredient concentrate with formoterol - Google Patents

Shelf-stable active ingredient concentrate with formoterol

Info

Publication number
NO20011663L
NO20011663L NO20011663A NO20011663A NO20011663L NO 20011663 L NO20011663 L NO 20011663L NO 20011663 A NO20011663 A NO 20011663A NO 20011663 A NO20011663 A NO 20011663A NO 20011663 L NO20011663 L NO 20011663L
Authority
NO
Norway
Prior art keywords
formoterol
shelf
active ingredient
stable active
ingredient concentrate
Prior art date
Application number
NO20011663A
Other languages
Norwegian (no)
Other versions
NO20011663D0 (en
Inventor
Dieter Hochrainer
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19847969A external-priority patent/DE19847969A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20011663D0 publication Critical patent/NO20011663D0/en
Publication of NO20011663L publication Critical patent/NO20011663L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20011663A 1998-10-17 2001-04-03 Shelf-stable active ingredient concentrate with formoterol NO20011663L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19847969A DE19847969A1 (en) 1998-10-17 1998-10-17 Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation
US11238098P 1998-12-14 1998-12-14
PCT/EP1999/007581 WO2000023065A2 (en) 1998-10-17 1999-10-09 Storable active substance concentrate with formoterol

Publications (2)

Publication Number Publication Date
NO20011663D0 NO20011663D0 (en) 2001-04-03
NO20011663L true NO20011663L (en) 2001-04-03

Family

ID=26049594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011663A NO20011663L (en) 1998-10-17 2001-04-03 Shelf-stable active ingredient concentrate with formoterol

Country Status (26)

Country Link
EP (1) EP1121112B1 (en)
JP (2) JP3636430B2 (en)
KR (1) KR100655100B1 (en)
CN (1) CN1187044C (en)
BG (1) BG65350B1 (en)
BR (1) BR9914507A (en)
CA (1) CA2343123C (en)
CZ (1) CZ20011362A3 (en)
DE (1) DE59901669D1 (en)
DK (1) DK1121112T3 (en)
EA (1) EA003960B1 (en)
EE (1) EE04219B1 (en)
ES (1) ES2178479T3 (en)
HK (1) HK1041448B (en)
HR (1) HRP20010255A2 (en)
HU (1) HUP0103925A3 (en)
ID (1) ID29605A (en)
IL (2) IL142494A0 (en)
NO (1) NO20011663L (en)
NZ (1) NZ511225A (en)
PL (1) PL348434A1 (en)
PT (1) PT1121112E (en)
SI (1) SI1121112T1 (en)
SK (1) SK285382B6 (en)
TR (1) TR200101096T2 (en)
WO (1) WO2000023065A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa Pressure metered dose inhaler.
IT1313553B1 (en) 1999-07-23 2002-09-09 Chiesi Farma Spa OPTIMIZED FORMULATIONS CONSTITUTED BY SOLUTIONS OF STEROIDS GIVEN BY INHALATION.
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa FORMULATIONS CONTAINING AN ANTICOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY.
DZ3358A1 (en) * 2000-05-22 2001-11-29 Chiesi Farma Spa PHARMACEUTICAL SOLUTION FORMULATIONS FOR PRESSURE INHALER-DOSERS
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ITRM20040268A1 (en) * 2004-05-31 2004-08-31 Italchimici S P A PHARMACEUTICAL FORMULATION OF A STABLE FORMOTEROL SOLUTION BY INHALATION AND ON ITS PREPARATION.
ITRM20050022A1 (en) 2005-01-19 2006-07-20 Italchimici S P A PHARMACEUTICAL FORMULATION OF A STABLE SOLUTION OF PROPYLENE GLYCOL CONTAINING FORMOTEROL BY INHALATION AND ITS PREPARATION PROCEDURE.
WO2007059620A1 (en) * 2005-11-23 2007-05-31 Feanny Stephen J Method for administering formoterol using a nebulizer
DE102006023756A1 (en) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanol-containing aerosol formulation for inhalation
CA2653744C (en) * 2006-05-26 2018-01-16 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010112358A2 (en) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (en) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalant apparatus and atomizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
AU2010323220B2 (en) 2009-11-25 2015-04-23 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (en) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
ES2836977T3 (en) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizer
JP6643231B2 (en) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
SG11201608891RA (en) 2014-05-07 2016-11-29 Boehringer Ingelheim Int Nebulizer, indicator device and container
CN107362140A (en) * 2016-05-11 2017-11-21 广东东阳光药业有限公司 Sprays and Spray Components
WO2020019952A1 (en) * 2018-07-26 2020-01-30 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrrolate salt and indacaterol salt, preparation method therefor, and uses thereof
CN110755414A (en) * 2019-11-12 2020-02-07 南京华盖制药有限公司 Arformoterol tartrate aerosol and preparation method thereof
BR112023001689A2 (en) * 2020-07-31 2023-05-02 Chemo Res S L COMBINATION THERAPY FOR INHALATION ADMINISTRATION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0717987B1 (en) * 1991-12-18 2001-08-29 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) * 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations

Also Published As

Publication number Publication date
EE200100224A (en) 2002-06-17
BR9914507A (en) 2001-06-26
EA200100439A1 (en) 2001-10-22
PT1121112E (en) 2002-11-29
CA2343123A1 (en) 2000-04-27
HRP20010255A2 (en) 2002-04-30
SK4942001A3 (en) 2001-09-11
EE04219B1 (en) 2004-02-16
IL142494A0 (en) 2002-03-10
HUP0103925A3 (en) 2003-05-28
HK1041448A1 (en) 2002-07-12
ES2178479T3 (en) 2002-12-16
EA003960B1 (en) 2003-10-30
CN1333682A (en) 2002-01-30
HK1041448B (en) 2005-05-13
CZ20011362A3 (en) 2001-09-12
HUP0103925A2 (en) 2002-05-29
BG65350B1 (en) 2008-03-31
NO20011663D0 (en) 2001-04-03
DK1121112T3 (en) 2002-09-16
BG105391A (en) 2001-11-30
KR100655100B1 (en) 2006-12-08
JP2002527473A (en) 2002-08-27
EP1121112B1 (en) 2002-06-05
SI1121112T1 (en) 2002-10-31
PL348434A1 (en) 2002-05-20
JP3636430B2 (en) 2005-04-06
IL142494A (en) 2006-04-10
WO2000023065A2 (en) 2000-04-27
ID29605A (en) 2001-09-06
DE59901669D1 (en) 2002-07-11
KR20010075637A (en) 2001-08-09
SK285382B6 (en) 2006-12-07
TR200101096T2 (en) 2001-12-21
EP1121112A2 (en) 2001-08-08
CN1187044C (en) 2005-02-02
JP2005047933A (en) 2005-02-24
CA2343123C (en) 2008-03-25
NZ511225A (en) 2003-08-29
WO2000023065A8 (en) 2001-02-22
WO2000023065A3 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
NO20011663D0 (en) Shelf-stable active ingredient concentrate with formoterol
ATE218331T1 (en) STORABLE ACTIVE CONCENTRATE WITH FORMOTEROL
NL300952I2 (en) Peramivir and pharmaceutically acceptable salts thereof
EE200000438A (en) Pharmaceutically active morpholinol
DK1087664T3 (en) Herbicidal mixtures with synergistic effect
ATE242249T1 (en) HERBICIDE ACTIVE 3-HYDROXY-4-ARYL-5-OXOPYRAZOLINE DERIVATIVES
DE59906523D1 (en) SYNERGISTIC INSECTICIDE MIXTURES
DE69902576D1 (en) ASEPTIC FASTENER
ID26936A (en) HERBISIDE COMPOSITION CONCENTRATE
NO20003640D0 (en) New dosage form
DE59902697D1 (en) AGROCHEMICAL FORMULATIONS
DK0934057T3 (en) Medicinal aerosol formulations with formoterol
NO20020793D0 (en) Active ingredient combination with clonidine
DK0934690T3 (en) Mowing device
ATE226012T1 (en) PESTICIDE AGENTS
ATE217021T1 (en) PREPARATION AGENTS
NO962806D0 (en) Absorbent object with invented barrier cuffs
PT1121107E (en) ORAL SERCALINE CONCENTRATE
DE59903807D1 (en) Active concentrate
FI931159A7 (en) Dosaerosoler, which contains the active ingredient flezelastin and related structures
ITMI20000629A0 (en) COMPOUNDS WITH ANTI-HIV ACTIVITY
ID23006A (en) 13-DIHIDRO-3 'AZIRIDINO ANTRASIKLINA
ATA109099A (en) MOWER
IS8740A (en) Pharmacologically active morpholinol
FI3913U1 (en) fairway

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application